POLYMYOSITIS
Clinical trials for POLYMYOSITIS explained in plain language.
Never miss a new study
Get alerted when new POLYMYOSITIS trials appear
Sign up with your email to follow new studies for POLYMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Year trial tests promising drug for debilitating muscle diseases
Disease control ENROLLING_BY_INVITATIONThis study follows up on previous participants to check the long-term safety and effectiveness of efgartigimod injections for inflammatory muscle diseases like dermatomyositis and polymyositis. About 240 adults who completed an earlier trial will receive the treatment for up to 5…
Matched conditions: POLYMYOSITIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Early, aggressive treatment could halt debilitating muscle disease
Disease control OngoingThis study is testing if adding a treatment called intravenous immunoglobulin (IVIg) to standard steroid therapy early in the course of inflammatory muscle diseases (myositis) leads to better and faster improvement. It involves 44 adults newly diagnosed with conditions like derma…
Matched conditions: POLYMYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC